LONDON/BENGALURU April 3 (Reuters) - Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from reciprocal tariffs, but executives ...

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy. Also read: Front-end manufacturing in U.S ...

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are ...

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from imposing new tariffs on the sector. While electronics and gems are hit by ...

On Wednesday, April 2, President Trump announced new reciprocal tariffs targeting several trading partners, including a 27 per cent "discounted reciprocal tariff" on imports from India. However, ...

Currently, US charges nearly zero duty on pharmaceutical imports, while India imposes around 10 percent tax on pharma imports from US. Domestic pharma companies are fearful of any potential impact ...

Indian pharmaceutical stocks soared after the US exempted drugs from reciprocal tariffs. Gland Pharma and Aurobindo Pharma led the rally, gaining over 14% and 9% respectively. New Delhi, Apr 3 (PTI) ...

Sun Pharmaceuticals led the gainers of Nifty 50 components to end 3.41 per cent positive at ₹1,772. The stock soared 6 per cent from the previous close to hit a high of ₹1,812.70.

US President Donald Trump renewed tariff threats by calling April 2 as ‘Liberation Day for US Economy and reiterated that United States will impose reciprocal tariffs. Given the extent of India ...

No matter how high the inflation is, their demand is inelastic. No matter how slow the current profit growth is, these companies spend on research and development (R&D) for future growth.

Stock market today: Indian pharma stocks extended their losing streak to the third consecutive trading session on Thursday, March 27, as concerns grew that US President Donald Trump may announce ...